Treatment of neuropathic pain with N-methyl-D-aspartate (NMDA) receptor antagonists

摘要

Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I):
where m, n, p, V, R1, R2, R3, R4, R5 and R6 are defined herein.
Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.